- Email: [email protected]
Prevention of cervical cancer: Effectiveness and public health impact of HPV vaccines, screening, and other policy options
Available online at www.sciencedirect.com
Preventive Medicine 46 (2008) 625 www.elsevier.com/locate/ypmed
Call for Papers
Prevention of cervical cancer: Effectiveness and public health impact of HPV vaccines, screening, and other policy options
Preventive Medicine invites researchers to submit papers on the roles of HPV vaccines, population screening, and primary care prevention in public and private policies aimed at decreasing the burden of cervical cancer and related diseases. Accepted papers will be published in a themed issue on this topic. Papers analyzing the pros and cons of the different policy alternatives in real populations will be given priority. Specific areas of interest include: • Relationships between the technological aspects of HPV vaccines and their eventual public health impacts • Effectiveness of alternative measures for controlling HPV infections and cervical cancer • External validity of trials of HPV vaccines for populations with high and low burdens of HPV infection and cervical cancer
doi:10.1016/S0091-7435(08)00281-8
• Long-term effectiveness of HPV vaccines to substantially decrease the population burden of cervical cancer and related pathologies • Realistic estimates of the impact of vaccinating millions of teenage girls for several decades on future cervical cancer incidence and mortality • Potential for iatrogenesis, “HPV-ization” and unnecessary medicalization • Role of health professions, disclosure of interests and ethical issues relevant to marketing of HPV vaccines and other private and public policies concerning cervical cancer The deadline for submissions is September 1, 2008. The guidelines for authors can be found on http://www. elsevier.com/pm. Papers should be 2500 words or less, except if they describe intervention trials, in which case they can be up to 3500 words. Reviews and commentaries will also be considered.
Preventive Medicine 46 (2008) 625 www.elsevier.com/locate/ypmed
Call for Papers
Prevention of cervical cancer: Effectiveness and public health impact of HPV vaccines, screening, and other policy options
Preventive Medicine invites researchers to submit papers on the roles of HPV vaccines, population screening, and primary care prevention in public and private policies aimed at decreasing the burden of cervical cancer and related diseases. Accepted papers will be published in a themed issue on this topic. Papers analyzing the pros and cons of the different policy alternatives in real populations will be given priority. Specific areas of interest include: • Relationships between the technological aspects of HPV vaccines and their eventual public health impacts • Effectiveness of alternative measures for controlling HPV infections and cervical cancer • External validity of trials of HPV vaccines for populations with high and low burdens of HPV infection and cervical cancer
doi:10.1016/S0091-7435(08)00281-8
• Long-term effectiveness of HPV vaccines to substantially decrease the population burden of cervical cancer and related pathologies • Realistic estimates of the impact of vaccinating millions of teenage girls for several decades on future cervical cancer incidence and mortality • Potential for iatrogenesis, “HPV-ization” and unnecessary medicalization • Role of health professions, disclosure of interests and ethical issues relevant to marketing of HPV vaccines and other private and public policies concerning cervical cancer The deadline for submissions is September 1, 2008. The guidelines for authors can be found on http://www. elsevier.com/pm. Papers should be 2500 words or less, except if they describe intervention trials, in which case they can be up to 3500 words. Reviews and commentaries will also be considered.